Traders assign a 91.5% probability to no new COVID variant of concern before 2027 because global surveillance through WHO and ECDC shows no lineages currently meet the criteria for elevated transmissibility, severity, or immune escape that would trigger that designation. Subvariants such as BA.3.2, monitored as a variant under monitoring since late 2024, have spread to dozens of countries without producing higher hospitalization rates or vaccine evasion demanding major policy shifts. Routine genomic tracking and wastewater data through mid-2026 confirm steady, low-level circulation of Omicron descendants rather than disruptive emergence. While unexpected mutations could still prompt reclassification in the remaining months, the absence of qualifying changes over the past year underpins the strong market consensus favoring resolution as “no.”